<DOC>
	<DOCNO>NCT02058446</DOCNO>
	<brief_summary>The antihypertensive effect Amlodipine/Valsartan combination evaluate worldwide population include Asian patient . The study primarily aim evaluate effectiveness Amlodipine/Valsartan combination patient essential hypertension Taiwan use prospective , open-label , non-randomized approach . The study also want investigate safety Amlodipine/Valsartan combination 6-week treatment period .</brief_summary>
	<brief_title>PMS Study Amlodipine/Valsartan Treatment Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine , Valsartan Drug Combination</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients 2080 year age Patients essential hypertension ( 90 mmHg ≤ DBP ≤ 110 mmHg and/or 140 mmHg ≤ SBP ≤ 180 mmHg ) whose BP adequately control amlodipine ( another CCB ) alone valsartan ( another ARB ) alone , antihypertensive monotherapy . Agree able follow study procedure Understand nature study , sign informed consent form Patients follow condition : 1 . Malignant ( history malignant ) hypertension 2 . Secondary hypertension 3 . Severe hypertension ( mean sit DBP ≥ 110 mmHg and/or mean sit SBP ≥ 180 mmHg ) 4 . A history hypertensive encephalopathy cerebrovascular accident 5 . Cerebrovascular accident , myocardial infraction within 3 month , type revascularization 6 . New York Heart Association class III IV congestive heart failure 7 . Second thirddegree heart block 8 . Angina pectoris 9 . Significant arrhythmia valvular heart disease 10 . Significant pancreatic , hepatic , renal disease 11 . Diabetes require insulin treatment poorly control type 2 diabetes Patients know contraindication history allergy CCBs ARBs . Female patient pregnant lactate . Male female patient childbearing potential agree use effective method contraception study Patients currently participate clinical trial within 30 day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>